Skip to content
PubMed This is a summary of 17 peer-reviewed journal articles Updated
Radiology · Hepatic Hemangioma

How Often Is a Large or Atypical Liver Hemangioma Scanned?

At a Glance

Large or atypical liver hemangiomas do not have one standard imaging schedule. Doctors tailor follow-up to diagnostic confidence, lesion size and growth, symptoms, cirrhosis or prior cancer, and whether comparable scans remain stable.

If you have been diagnosed with a large, growing, or atypical liver hemangioma, you likely want to know exactly when your next scan should be. However, there is no single, universal follow-up schedule for monitoring these lesions [1][2][3]. The timeline for your next imaging test is highly individualized. It depends on the size of the lesion, whether you have symptoms, your overall health risk, and—most importantly—how confident your doctor is in the initial diagnosis [1][4].

What Your Imaging Results Might Mean in Practice

Your monitoring plan generally falls into one of these clinical pathways:

  • Confidently Diagnosed, Typical Hemangiomas: If high-quality imaging definitively shows a classic hemangioma, routine follow-up scans are often not required, as these are overwhelmingly benign [1][5].
  • Atypical or Indeterminate Lesions: Hearing the word “atypical” can be frightening, but it simply means the lesion did not show the classic appearance on the initial scan. However, these require diagnostic clarification rather than routine surveillance [6].
  • Large but Asymptomatic Lesions: Thresholds vary, but “large” (often >5 cm) or “giant” (often >10 cm) hemangiomas may be monitored to check for growth [7][4]. Size alone does not mean it is cancerous or that it requires treatment [7][8].
  • Underlying Cirrhosis or Prior Cancer: If you have cirrhosis (advanced liver scarring) or a prior history of cancer, an atypical lesion requires specialized review. Your care team will use specific protocols to rule out metastasis (cancer that has spread from another organ) or a different type of liver tumor [9][10]. Simply scanning more often is not the solution; achieving a definitive diagnosis is.

Handling Diagnostic Uncertainty for Atypical Lesions

Establishing a definitive diagnosis for an atypical lesion is the top priority because they can occasionally mimic cancer [10][11]. In one specific multicenter study of 327 lesions that had been referred to specialists as “atypical hemangiomas,” about 7% were ultimately diagnosed as malignant [10]. While this statistic highlights the need for careful evaluation, it reflects a selected group of uncertain lesions, not the risk for a classic hemangioma.

If your initial scan was inconclusive, your doctor will likely recommend contrast-enhanced MRI or contrast-enhanced ultrasound (CEUS) [6][12]. These use contrast agents (given intravenously) to highlight blood flow and structure. If the diagnosis remains uncertain after expert review, a short-interval follow-up scan may be recommended [12].

Because hemangiomas are made of blood vessels, a tissue biopsy carries a risk of bleeding [12][13]. Therefore, a biopsy is rarely performed and is only considered when a specialist liver team determines that the diagnostic benefit clearly outweighs the risks [6][13].

Factors That Influence Your Monitoring Plan

Once your clinician is confident the diagnosis is secure, several factors dictate how often your hemangioma needs to be rechecked:

  • Size and Growth Pattern: Large or giant hemangiomas have a higher potential for growth and may be monitored periodically [4][2]. In long-term studies, large untreated hemangiomas grew at a median rate of about 2.5 mm per year, and many caused no symptoms [2].
  • Pregnancy Plans: Hormonal changes during pregnancy can potentially influence hemangioma growth, though most pregnancies proceed without complications [14]. A multidisciplinary discussion before conception is advised to manage clinical risks and carefully select the safest imaging and contrast agents during pregnancy [14].

When to Seek Immediate Medical Attention

If you have a known hemangioma, contact your specialist or seek emergency care if you experience any of the following red-flag symptoms:

  • Sudden, severe abdominal pain
  • Fainting, severe dizziness, or rapidly worsening weakness
  • Signs of coagulopathy (a rare disorder affecting blood clotting), which may appear as unusual or excessive bruising and bleeding [15][1]
  • Symptoms of compression, such as feeling full very quickly (early satiety) or jaundice [15][16]

Consistent Imaging Is Key

When monitoring a liver lesion, it is very helpful to use comparable imaging when clinically appropriate [17]. This means subsequent scans should ideally use the same technique (e.g., MRI compared to MRI) and similar contrast agents, as switching between ultrasound, CT, and MRI can yield misleading size or appearance changes [17]. Always ensure your radiologist has access to your prior images and reports for direct comparison.

How Stability Changes the Plan

The goal of serial imaging is to establish a pattern. Many hemangiomas remain completely stable or even shrink over time [5][2]. If your hemangioma has shown consistent stability over comparable scans, and there is high diagnostic confidence, your specialist may recommend spacing out your imaging appointments or discontinuing routine monitoring altogether [1][5]. However, stability alone does not resolve an atypical appearance or eliminate the need for careful follow-up in someone with cirrhosis or a prior cancer.

Common questions in this guide

Is there a standard scan schedule for a large or atypical liver hemangioma?
No. The timing is individualized based on the lesion’s size and growth, your symptoms and health history, and how certain your clinician is that it is a hemangioma. A classic hemangioma confirmed by high-quality imaging may not need routine scans, while an atypical lesion may need further evaluation first.
What scan is used when a liver hemangioma does not look typical?
A magnetic resonance imaging scan with contrast or a contrast-enhanced ultrasound (CEUS) is often used to show blood flow and the lesion’s structure more clearly. If uncertainty remains after specialist review, your doctor may recommend another scan after a short interval. The choice depends on your medical history and the available expertise.
Does having a large liver hemangioma mean that I have cancer?
No. Large or giant hemangiomas can still be benign, and size alone does not prove cancer or mean treatment is needed. An atypical appearance, cirrhosis, or a history of cancer may require specialist review to make sure another liver tumor or cancer spread is not being missed.
Why is it helpful to use the same type of scan each time?
Comparing similar studies, such as MRI with MRI, makes it easier to tell whether the lesion has truly changed. Switching among ultrasound, CT, and MRI can make its size or appearance seem different even when it is stable. Providing prior images and reports allows the radiologist to compare them directly.
When can follow-up scans for a liver hemangioma be spaced farther apart?
If high-quality, comparable scans show that the lesion is stable and the diagnosis is secure, a specialist may lengthen the interval between scans or stop routine monitoring. Stability alone may not be enough when the lesion still looks atypical or when you have cirrhosis or a prior cancer.
What should I know about pregnancy while my liver hemangioma is being monitored?
Pregnancy-related hormonal changes may affect hemangioma growth, although most pregnancies proceed without complications. Tell your liver specialist before pregnancy when possible so the team can plan appropriate follow-up and choose imaging and contrast agents carefully.
Which symptoms should prompt urgent medical care with a liver hemangioma?
Seek urgent medical attention for sudden severe abdominal pain, fainting, severe dizziness, rapidly worsening weakness, unusual or excessive bruising or bleeding, jaundice, or feeling full very quickly. These symptoms can have causes other than a hemangioma, but they need prompt assessment.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is my liver lesion considered typical or atypical, and what is your level of confidence in the diagnosis?
  2. 2.Are my symptoms likely related to this hemangioma, or should we look for other causes?
  3. 3.Should my case be reviewed by a specialist multidisciplinary liver or radiology team?
  4. 4.What time interval do you recommend for my next imaging test, and will we use a comparable scan (like MRI to MRI)?
  5. 5.What specific imaging and contrast approach is safest if I become pregnant while monitoring this lesion?
  6. 6.How many stable scans would you need to see before we can safely lengthen the time between follow-ups or stop checking altogether?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (17)
  1. 1

    Real-world data on the clinicopathological traits and outcomes of hospitalized liver hemangioma patients: a multicenter study.

    Tang T, Wang X, Mao Y, et al.

    Annals of translational medicine 2021; (9(13)):1067 doi:10.21037/atm-20-4684.

    PMID: 34422979
  2. 2

    Natural History of Hepatic Hemangiomas Larger Than 10 cm: Imaging Findings and Clinical Course of 22 Cases.

    Onishi Y, Ohno T, Shimizu H, et al.

    Cureus 2023; (15(12)):e50563 doi:10.7759/cureus.50563.

    PMID: 38226088
  3. 3

    Hepatic cavernous hemangiomas: long-term (> 5 years) follow-up changes on contrast-enhanced dynamic computed tomography or magnetic resonance imaging and determinant factors of the size change.

    Choi J, Yu JS, Cho ES, et al.

    La Radiologia medica 2018; (123(5)):323-330 doi:10.1007/s11547-018-0854-y.

    PMID: 29357040
  4. 4

    Giant Liver Hemangiomas: A Plea for Early Surgical Referral and Resection.

    Chang A, Ruch B, Khan A, et al.

    Case reports in surgery 2020; (2020()):5923787 doi:10.1155/2020/5923787.

    PMID: 32607273
  5. 5

    New recognition of the natural history and growth pattern of hepatic hemangioma in adults.

    Jing L, Liang H, Caifeng L, et al.

    Hepatology research : the official journal of the Japan Society of Hepatology 2016; (46(8)):727-33 doi:10.1111/hepr.12610.

    PMID: 26492419
  6. 6

    One stop shop approach for the diagnosis of liver hemangioma.

    Sandulescu LD, Urhut CM, Sandulescu SM, et al.

    World journal of hepatology 2021; (13(12)):1892-1908 doi:10.4254/wjh.v13.i12.1892.

    PMID: 35069996
  7. 7

    Giant cavernous liver hemangiomas: is it the time to change the size categories?

    Di Carlo I, Koshy R, Al Mudares S, et al.

    Hepatobiliary & pancreatic diseases international : HBPD INT 2016; (15(1)):21-9 doi:10.1016/s1499-3872(15)60035-2.

    PMID: 26818540
  8. 8

    Tumor size is not a criterion for resection during the management of giant hemangioma of the liver.

    Dong J, Zhang M, Chen JQ, et al.

    European journal of gastroenterology & hepatology 2015; (27(6)):686-91 doi:10.1097/MEG.0000000000000344.

    PMID: 25923944
  9. 9

    Evaluation of Primary Liver Cancers Using Hepatocyte-Specific Contrast-Enhanced MRI: Pitfalls and Potential Tips.

    Kim JH, Yoon JH, Joo I, Lee JM

    Journal of magnetic resonance imaging : JMRI 2021; (53(3)):655-675 doi:10.1002/jmri.27213.

    PMID: 32700807
  10. 10

    Use of the Term "Atypical Hepatic Hemangioma" in Radiology Reports: An Analysis of Diagnostic Precision.

    Tamir S, Krutik T, Kedem Mashraki R, et al.

    Journal of clinical medicine 2026; (15(15)) doi:10.3390/jcm15155923.

    PMID: 42590025
  11. 11

    Proposal of size-based surgical indication criteria for liver hemangioma based on a nationwide survey in Japan.

    Sakamoto Y, Kokudo N, Watadani T, et al.

    Journal of hepato-biliary-pancreatic sciences 2017; (24(7)):417-425 doi:10.1002/jhbp.464.

    PMID: 28516570
  12. 12

    Practical approach to diagnose and manage benign liver masses.

    Reguram R, Ghonge A, Tse J, Dhanasekaran R

    Hepatology communications 2024; (8(11)) doi:10.1097/HC9.0000000000000560.

    PMID: 39470338
  13. 13

    Utility of contrast-enhanced ultrasonography with perflubutane in evaluating indications for diagnostic percutaneous tumor biopsy in a case of hepatic sclerosed hemangioma.

    Ando Y, Ishigami M, Ishizu Y, et al.

    Clinical journal of gastroenterology 2018; (11(6)):514-520 doi:10.1007/s12328-018-0880-2.

    PMID: 29931440
  14. 14

    Giant intrahepatic venous malformation with localized intravascular coagulopathy. Follow-up and treatment during pregnancy.

    Serrano F, Bisdorff-Bresson A, Sroussi J, et al.

    Journal de medecine vasculaire 2020; (45(6)):309-315 doi:10.1016/j.jdmv.2020.10.121.

    PMID: 33248533
  15. 15

    Prevalence and Characteristics of Hepatic Hemangioma Associated with Coagulopathy and Its Predictive Risk Factors.

    Maruyama S, Matono T, Koda M

    Journal of clinical medicine 2022; (11(15)) doi:10.3390/jcm11154347.

    PMID: 35893437
  16. 16

    Giant pedunculated hepatic hemangioma accompanied by a 10-year history of taking oral contraceptive: A case report and literature review.

    Samidoust P, Moayerifar M, Mohammadian M, et al.

    Clinical case reports 2024; (12(6)):e8995 doi:10.1002/ccr3.8995.

    PMID: 38803323
  17. 17

    Differences between CEUS LI-RADS and CECT LI-RADS in the diagnosis of focal liver lesions in patients at risk for HCC.

    Wen R, Huang W, Song R, et al.

    BMC medical imaging 2023; (23(1)):122 doi:10.1186/s12880-023-01088-1.

    PMID: 37697248

This page is for informational purposes only and does not constitute medical advice. A radiologist or liver specialist should determine your scan schedule and interpret your results based on your complete health history.

Get notified when new evidence is published on liver hemangioma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.